In general, your posts strike me as somewhat gullible with respect to VRUS’ talking points
If trusting management, and believing in the science, is being gullible I guess I'm guilty as charged. Perhaps it's your scepticism that's the issue here.
VRUS is a fine company that has a nice portfolio of HCV drugs, but they do not have anything radically different from the pyrimidine and purine nukes of other HCV companies
Do you consider a dual nuke DAA (without a third drug) radical?
“I am a big believer in giving it all away and have always said that the best financial planning ends with bouncing the check to the undertaker.”